Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-170830
Filing Date
2021-05-24
Accepted
2021-05-24 16:03:04
Documents
7
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d13011d10ka.htm 10-K/A 903174
2 EX-4.2 d13011dex42.htm EX-4.2 216691
3 EX-31.1 d13011dex311.htm EX-31.1 6903
4 EX-31.2 d13011dex312.htm EX-31.2 6940
5 EX-32.1 d13011dex321.htm EX-32.1 4269
6 EX-32.2 d13011dex322.htm EX-32.2 4262
7 GRAPHIC g13011g57k98.jpg GRAPHIC 181176
  Complete submission text file 0001193125-21-170830.txt   1392849
Mailing Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Acquisition Corp (Filer) CIK: 0001828326 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39765 | Film No.: 21954799
SIC: 6770 Blank Checks